Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo(City of Hope), Louis M. Staudt(National Cancer Institute), Wing C. Chan(Ontario Institute for Cancer Research), Joseph M. Connors, Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Elı́as Campo(Hospital Clínic de Barcelona), Randy D. Gascoyne(BC Cancer Agency), Sameer Jhavar(National Cancer Institute), John Powell(National Institutes of Health), Yandan Yang(National Cancer Institute), Weihong Xu(World Wide Web Consortium), Paul B. Romesser(Howard Hughes Medical Institute), James R. Cook(Cleveland Clinic), Roland Schmitz(World Wide Web Consortium), Holger Kohlhammer(Max Planck Institute for Metabolism Research), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Rita M. Braziel(Oregon Health & Science University), Wenming Xiao(World Wide Web Consortium), Kian‐Huat Lim(Washington University in St. Louis), Jan Delabie, Ryan M. Young(Denver Health Medical Center), George W. Wright(National Cancer Institute), Elaine S. Jaffe(National Cancer Institute), Hong Zhao(Northwestern University), Richard I. Fisher(University of Rochester), Raymond R. Tubbs(Cleveland Clinic), Hans Konrad Müller‐Hermelink(University of Würzburg), D D Weisenburger(University of Nebraska Medical Center), Arthur L. Shaffer(World Wide Web Consortium), Erlend B. Smeland(Norwegian Cancer Society), Lisa M. Rimsza(Banner - University Medical Center Tucson)
Cited by 1,508
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k